Abstract

This new project was only approved in the last month of FY96. A literature search suggested that vaccines for yellow fever and mumps are highly suitable for MAPREC testing, because nucleotides important in virulence have been identified. Primer sequences for reverse-transcriptase PCR amplification and restriction endonucleases suitable for quantitative cleavage reactions have been selected.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BR005005-01
Application #
2456647
Study Section
Special Emphasis Panel (LMD)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost